We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00125437
Recruitment Status : Terminated (Poor compliance with the therapy and lot of patients were lost to follow up.)
First Posted : August 1, 2005
Last Update Posted : July 15, 2009
Information provided by:
Hebei Medical University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Estimated Study Completion Date : September 2009